Lymphocyte subpopulations and lymphocyte function in phenytoin-treated patients with epilepsy. 1982

N E Gilhus, and R Matre, and J A Aarli

The number of leukocytes and the percentage of cells in various mononuclear subpopulations were determined in 22 patients with epilepsy. The lymphocyte response to PHA were examined in the patients and in selected controls. The patients were grouped according to phenytoin treatment at present or previously, and according to the presence or absence of serum IgA depression. Patients taking phenytoin demonstrated reduced leukocyte counts. The lowest counts were found in phenytoin-treated patients with markedly reduced IgA concentrations. The number of lymphocytes were reduced more than the total leukocyte count in the patients. No significant differences were observed between patients and controls regarding percentage of cells with membrane-bound immunoglobulins, active E-rosetting cells, AET-rosetting cells, EA-rosetting cells, EAC-rosetting cells, and cells with a capacity of phagocytosis. The mean response to PHA stimulation (PHA concentration 0.6 micrograms/ml) was 4634 counts per minute in the patients and 6132 counts per minute in the controls. However, the response to this stimulation varied considerably between individuals in both groups, and the difference between the 2 groups was not statistically significant.

UI MeSH Term Description Entries
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010586 Phagocytes Cells that can carry out the process of PHAGOCYTOSIS. Phagocyte,Phagocytic Cell,Phagocytic Cells,Cell, Phagocytic,Cells, Phagocytic
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D004406 Dysgammaglobulinemia An immunologic deficiency state characterized by selective deficiencies of one or more, but not all, classes of immunoglobulins. Dysgammaglobulinemias
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N E Gilhus, and R Matre, and J A Aarli
January 1989, Immunopharmacology and immunotoxicology,
N E Gilhus, and R Matre, and J A Aarli
January 1989, Journal of child neurology,
N E Gilhus, and R Matre, and J A Aarli
November 1996, Epilepsia,
N E Gilhus, and R Matre, and J A Aarli
January 2007, Advances in experimental medicine and biology,
N E Gilhus, and R Matre, and J A Aarli
July 1976, Lancet (London, England),
N E Gilhus, and R Matre, and J A Aarli
February 1987, Transplantation proceedings,
N E Gilhus, and R Matre, and J A Aarli
January 1989, Epilepsia,
N E Gilhus, and R Matre, and J A Aarli
October 1992, The Indian journal of medical research,
N E Gilhus, and R Matre, and J A Aarli
January 1983, The New England journal of medicine,
Copied contents to your clipboard!